Go to content
UR Home

Vasoplegic Syndrome after Oral Nimodipine Application in Patients with Subarachnoid Hemorrhage

URN to cite this document:
DOI to cite this document:
Bele, Sylvia ; Scheitzach, J. ; Kieninger, Martn ; Hochreiter, A. ; Schödel, Petra ; Bründl, Elisabeth ; Schebesch, Karl-Michael ; Brawanski, Alexander
Date of publication of this fulltext: 05 Mar 2015 12:48


the underlying aneurysm leading to decrease of immediate complications such as rebleeding, cerebral vasospasm remains the major cause for mortality and morbidity after subarachnoid hemorrhage. The only FDA approved drug for treatment of cerebral vasospasm is the calcium antagonist Nimodipine that has shown beneficial effects on outcome. It is safe, cost efficient and the most widely studied drug ...


Owner only: item control page
  1. Homepage UR

University Library

Publication Server


Publishing: oa@ur.de
0941 943 -4239 or -69394

Dissertations: dissertationen@ur.de
0941 943 -3904

Research data: datahub@ur.de
0941 943 -5707

Contact persons